Tepylute
Active Ingredient(s): ThiotepaFDA Approved: * June 25, 2024
Pharm Company: * SHORLA
Category: Cancer
Thiotepa (INN[3]), sold under the brand name Tepadina, is a medication used to treat cancer.[1][2][4] Thiotepa is an organophosphorus compound with the formula (C2H4N)3PS.[5] It is an analog of N,N′,N′′-triethylenephosphoramide (TEPA), which contains tetrahedral phosphorus and is structurally akin to phosphate. It is manufactured by heating aziridine with thiophosphoryl chloride.[citation... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.